Virginia Tech® home

Innovative Strategies for Overcoming Challenges in Brain Tumor Treatment

Insert your title here

Your Text Here
Kristin Huntoon, Ph.D., D.O.

Kristin Huntoon, Ph.D., D.O.

Assistant Professor
Department of Neurosurgery
University of Arizona 
View Speaker Profile
Pioneers in Biomedical Research Seminar

Innovative Strategies for Overcoming Challenges in Brain Tumor Treatment

Date: Jan. 16, 2026

Time: 11 a.m. to noon

About this Seminar

Glioblastoma (GBM) and diffuse intrinsic pontine glioma (DIPG) are aggressive brain tumors with limited treatment options. Emerging strategies harness engineered CAR macrophages to enhance immune responses, while tumor-derived exosomes provide novel biomarkers and therapeutic targets. Telomerase inhibition offers a promising avenue for disrupting tumor proliferation at the genomic level. Additionally, ultrasound microbubble technology enables targeted delivery of therapeutics across the blood-brain barrier, enhancing precision and efficacy. This talk will explore the synergistic integration of these cutting-edge approaches to develop next-generation therapies for GBM and DIPG.

Additional Details

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Center — Roanoke. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.

You May Also Be Interested In...

  • Home Item
    Exercise, the Fountain of Youth?
    Exercise, the Fountain of Youth? , home

    Oct. 15, 2026, 5:30 p.m. (Reception at 5 p.m.) | Zhen Yan, Ph.D., Professor and Director, Center for Exercise Medicine Research, Fralin Biomedical Research Institute at VTC | Maury Strauss Distinguished Public Lecture

  • Home Item
    Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies
    Data-Driven Discovery of Secreted Proteins as Cancer Immunotherapies , home

    Oct. 16, 2026, 11:00 a.m. | Peng Jiang, Ph.D., Senior Investigator, National Cancer Institute, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute and the Cancer Research Center — D.C.

  • Home Item
    Mapping Different Excitatory and Inhibitory Input Types onto Single Cortical Pyramidal Neurons
    Mapping Different Excitatory and Inhibitory Input Types onto Single Cortical Pyramidal Neurons , home

    Oct. 30, 2026, 11:00 a.m. | Elly Nedivi, Ph.D., William R. (1964) & Linda R. Young Professor of Neuroscience, The Picower Institute for Learning & Memory, Departments of Brain and Cognitive Sciences, and Biology, Massachusetts Institute of Technology | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Neurobiology Research

  • Home Item
    Drug Discovery in the Next Decade: From Genome Medicine to Clinical Trial in a Dish
    Drug Discovery in the Next Decade: From Genome Medicine to Clinical Trial in a Dish , home

    Nov. 5, 2026, 5:30 p.m. (Reception at 5 p.m.) | Joseph Wu, M.D., Ph.D., Professor and Director, Stanford Cardiovascular Institute, Stanford University School of Medicine | Maury Strauss Distinguished Public Lecture

  • Home Item
    Presenting Therapeutic Peptides Using Synthetic Polymers
    Presenting Therapeutic Peptides Using Synthetic Polymers , home

    Nov. 13, 2026, 11:00 a.m. | Rachel A. Letteri, Ph.D., Associate Professor, Departments of Chemical Engineering, University of Virginia | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Vascular and Heart Research

  • Home Item
    The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function
    The Bitter Truth: Alcohol Use and Its Effects on Chemosensory Function , home

    Dec. 11, 2026, 11:00 a.m. | Paule V. Joseph, Ph.D., MBA, Lasker Clinical Research Scholar, NIH Distinguished Scholar, Acting Chief, Section of Sensory Science and Metabolism Unit, NIDCD; Co-Director, National Smell and Taste Center; Attending Nurse Practitioner, Division of Intramural Clinical and Biological Research; National Institute on Alcohol Abuse and Alcoholism, National Institute on Deafness and Other Communication Disorders | Co-Sponsored by the Fralin Biomedical Research Institute and the Center for Health Behaviors Research